Skip to main content
. 2020 Feb 26;27(5):1208–1216. doi: 10.1016/j.sjbs.2020.02.010

Fig. 3.

Fig. 3

(A) Standard drug co-crystallized with (ID: 2az5) through the formation of hydrophobic-hydrophobic interactions. (B) Compound 5a with (ID: 2az5) docked outside the receptor through the formation of hydrophobic-hydrophobic interactions. (C) Compound 5a with (ID: 2az5) docked with receptor overlay with standard drugs through the formation of hydrophobic-hydrophobic interactions.